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Commentaries

Location, location, location:
important for jet-lagged circadian loops
Mary Harrington
Department of Psychology, Smith College, Northampton, Massachusetts, USA.

It is now believed that frequent jet lag or shifts of daily rhythms caused by
rotating shift work can lead to deleterious health outcomes. Indeed, many
serious health problems, including breast cancer, stroke, and cardiovascular disease, have been linked to an occupational history of shift work. This
has heightened interest in better understanding the biological responses to
jet lag and shift work, with the hope that this will pave the way to developing
compounds that can help people avoid their negative health consequences.
In this context, a report in this issue of the JCI takes us to a new level of
understanding of the molecular control of the resetting of the multitude of
internal biological clocks disrupted in a mouse model of jet lag.
Jet lag can seem like a minor discomfort,
but studies are now suggesting that frequent jet lag or shifts of daily rhythms as
a result of rotating shift work can lead to
many deleterious health outcomes. Breast
cancer, reproductive disorders, cardiovascular disease, stroke, and metabolic syndrome are all linked to an occupational
history of shift work (1–3). Experiments
modeling chronic jet lag have shown that
it can speed up tumor growth (4) and bring
on early mortality in aged mice (5), as well
as lower the survival rate for hamsters with
impaired heart function (6). The International Agency for Research on Cancer, a
unit of the World Health Organization,
has declared that night shift work is also
a probable carcinogen (7). These serious health concerns heighten our interest in better understanding the biological
responses to jet lag and shift work.
Why do we suffer malaise
from shift work and jet lag?
The malaise from shift work and jet lag is
thought to arise from the dynamic properties of a multitude of internal biological clocks responding to environmental
inputs. Many of our tissues have the ability to maintain 24-hour cycles with fair
accuracy (8). Because they are not precisely 24-hour clocks, but mark time for
approximately (i.e., circa) a day, they are
referred to as circadian clocks. They are
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kept aligned with the cycles of the planet in
part by the regulatory influence of a small
group of neurons in a region of the hypothalamus known as the suprachiasmatic
nucleus (SCN; ref. 8). The SCN is a collection of many cells with molecular clocks
that communicate to maintain a coupled,
coherent, and rhythmic output. The SCN
receives direct input from the retina and
thus is informed immediately when light
is detected. Light appearing at unexpected
times, when the internal clocks expect to be
in the darkness of night, will reset the internal rhythm of the SCN. Then the SCN cells
will serve as the master pacemaker, helping
all the other clocks within the organism
to realign to the new light/dark cycle. The
dynamics of how the SCN and this community of clocks realign to new light/dark
cycles are thought to underlie jet lag.
Within each SCN cell, the perception
of time of day is maintained by a network
of interlinked genes and proteins (9). In
particular, the proteins clock (CLK) and
brain and muscle aryl hydrocarbon receptor nuclear translocator–like (ARNTL; also
referred to as BMAL1) act by activating
transcription and driving the expression
of a number of genes (Figure 1). The genes
driven by CLK and ARNTL include the
period genes, such as period 1 (Per1) and
Per2, and the cryptochrome genes, such as
cryptochrome 1 (Cry1) and Cry2. The gene
products — PER1, PER2, CRY1, and CRY2,
respectively — spend some time milling
around in the cytoplasm of the cell, getting
phosphorylated and forming dimers. Eventually, they are suited for nuclear translocation, at which time they provide a negative
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feedback signal inhibiting the activational
drive of CLK and ARNTL that led to their
own production. After some time, period/
cryptochrome inhibition is released, and
CLK and ARNTL are free to begin the cycle
again. This is a simplified example of the
molecular mechanism underlying circadian
rhythms; there are several other genes playing feedback roles as well. For example, the
genes encoding nuclear receptor subfamily 1,
group D, member 1 (NR1D1; also known
as REV-ERBa) and RAR-related orphan
receptor a (RORa) mediate a feedback loop
to provide rhythmic inhibitory and activating drive, respectively, to Arntl. Dbp, which
encodes D-element–binding protein (DBP),
is sensitive to the rhythmic transcriptional
activation of CLK and ARNTL and shows
a regular circadian rhythm in expression,
a reflection of the intricate mechanism of
the molecular clock within each cell. DBP
can act as a transcriptional activator for
other, downstream genes. The concurrent
loops of this system are numerous, in that
many of the key genes contain promoter elements sensitive to fluctuations of CLK and
ARNTL, which bind E-boxes; NR1D1, which
binds REV-ERBa/ROR–binding elements
(RREs); and DBP, which binds D-boxes (9).
A similar clock is present in many other
cells of the body, although in some cases, the
exact timekeepers are slightly altered. While
the cellular clocks in the SCN can be reset by
light because retinal input can increase levels of PER1 and PER2, how are clocks in cells
outside of the brain reset? Levels of physical
activity could be important, as could daily
cycles of food intake or body temperature.
Neural or humoral pathways might also be
important in helping all the body clocks
stay in step. One important hormonal input
is corticosterone, a glucocorticoid secreted
by the adrenal gland. Glucocorticoids can
directly increase Per1 gene transcription
(10). Glucocorticoid signaling can reset
peripheral clocks (11) through what appears
to be direct action on those cells; SCN cells
do not express glucocorticoid receptors, but
are thought to be responsive to this signal
through intermediate pathways.
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Figure 1
An interconnected network of genes and gene products underlies circadian
rhythm generation in the mammalian SCN cell. The proteins CLK and ARNTL
act by activating transcription and driving the expression of a number of genes.
The products of these genes, including PER1, PER2, CRY1, and CRY2, provide
a negative feedback signal to inhibit the activational drive of CLK and ARNTL.
Several other genes also have feedback roles; for example, the genes encoding
NR1D1 and RORa mediate a feedback loop to provide rhythmic inhibitory and
activating drive, respectively, to the gene encoding ARNTL. Because Dbp is
sensitive to the rhythmic transcriptional activation of CLK and ARNTL, DBP can
act as a transcriptional activator for other, downstream genes.

Jet lag varies with tissue location
A key study showed that the SCN can adjust
quickly to the different light cycle of a new
time zone, but the extra-SCN circadian clock
in the liver can take more than a week to get
in sync (12). This study used animals with
a Per1-luciferase reporter transgene that
allowed rhythms of cultured tissues to be
measured following shifts of the light/dark
cycle. Subsequent studies have shown that jet
lag not only produces internal temporal disorder of the relationship between the SCN
and extra-SCN clocks, but also throws the
multitude of cells within the SCN into a state
of temporal disarray (13–15). Cells in more
ventral areas of the SCN shift more rapidly
than do those in more dorsal regions (13).
A study in this issue of the JCI by
Kiessling, Eichele, and Oster (16) takes us
to a new level of understanding of jet lag.
This study is unique in that 5 of the key
genes important in generating circadian
rhythms were assayed in 6 tissues of the body
over multiple times and multiple days as the
animal experienced jet lag. Surprisingly, the
individual players in the complex network of
genes and proteins constituting the molecular clock shifted to a new light/dark cycle at
different rates. This result was observed both
within and across tissues. For example, the
period genes shifted quickly in SCN samples,
but Dbp, Nr1d1, and Arntl lagged behind. Conclusions from prior work on how clocks reset
using markers for period genes now must be
qualified, because other genes within SCN
cells apparently do not shift so rapidly, confirming an earlier report that cryptochrome
genes shift more slowly than do period genes
in the SCN (17). Interestingly, timing of the
daily use of a running wheel shifted at a rate
similar to the slowest genes in the SCN (16).
The extra-SCN tissues sampled showed a
variety of shifting patterns. Most different
from the SCN was the pancreas, in which
Nr1d1 showed the fastest resetting and Per1,
Per2, Dbp, and Arntl, were slower to adjust.
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Thus, each tissue showed a uniquely determined pattern of jet lag, perhaps reflecting
their unique input pathways (8).
The adrenal gland is a drag
One original insight from the study of
Kiessling et al. (16) is the demonstration that
a circadian oscillator remote from the SCN
can impede the pacemaker action of the SCN.
The clock within the adrenal gland influences the rhythm of glucocorticoid in the
blood. The authors propose that this rhythm
provides stabilizing feedback to the SCN and
can help SCN cells resist shifts to sporadic
stimuli. This was shown by the demonstration that ablation of the adrenal clock sped
up adjustment of the SCN to a shifted light/
dark cycle (16), confirming a prior report that
ablation of the entire adrenal gland sped up
adjustment of behavioral rhythms to shifted
light/dark cycles (18). This demonstration of
a restraining feedback from a peripheral oscillator to the SCN challenges the older, more
hierarchical, understanding of the structure
of the circadian system as a system with a
core pacemaker and many slave oscillators
(Figure 2). The present finding supports the
current understanding of the circadian system as a network with feedback interactions
even from the peripheral oscillators to the
main pacemaker in the SCN.
Developing treatments
for future frequent flyers
Kiessling et al. also found that pharmacological treatments that altered levels of corticosterone could either accelerate or prolong
jet lag in the mice, depending on the time of
day of treatment (16). This adds to several
recent observations that pharmacological
treatments can speed adjustment to shifted
light/dark cycles; for example, jet lag has
been shown to be lessened in hamsters treated with sildenafil (19) or NAN-190, a drug
that alters serotonin responses (20). Further
development of such compounds might
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reduce the negative health consequences of
jet lag and shift work. Improved methods for
adjusting to new time zones could also help
shorten the accompanying temporal disorder (21, 22). Whether shifting rapidly is actually better or worse for one’s health remains
critical to sort out; researchers have been trying to find treatments that speed the rate of
resynchronization, but we must be cautious
about recommending such treatments until
it is clear that these rapid shifts are not more

Figure 2
Cellular clock genes adjust to new time zones
at different rates in different body organs. (A)
In the central brain clock, the SCN, Per1 and
Per2 lead the system in shifting. (B) Conversely, in the pancreas, Nr1d1 appears to
take the lead. (C) The liver circadian clock
shows an intermediate pattern. Red indicates
genes slower to adjust to jet lag, and green
denotes genes faster to respond, as indicated
by Kiessling et al. (16).
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harmful than more gradual adjustments.
An important caution in interpreting the
work of Kiessling et al. is that the researchers measured gene expression at the level of
mRNA (16). It is important to determine the
dynamics of key proteins and posttranslational modifications of proteins to more
fully appreciate the relevance of these findings. Development of methods for noninvasive imaging of circadian clock dynamics in
various tissues within an animal would allow
studies similar to this one to become more
routine and would better equip us to develop
effective treatments for jet lag.
Our current understanding of jet lag
incorporates disorder at many levels. Disorder can exist between the timing of the
organism and the environment, within
the different organs in the organism, and
among the cells within a single tissue. The
study in this issue demonstrates that jet lag
may also include disorder among the circadian clock genes within a cell.
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An energetic tale of AMPK-independent
effects of metformin
Russell A. Miller and Morris J. Birnbaum
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Metformin has become a mainstay in the modest therapeutic armamentarium for the treatment of the insulin resistance of type 2 diabetes mellitus. Although metformin functions primarily by reducing hepatic glucose
output, the molecular mechanism mediating this effect had remained elusive until recently. Metformin impairs ATP production, activating the conserved sensor of nutritional stress AMP-activated protein kinase (AMPK),
thus providing a plausible and generally accepted model for suppression of
gluconeogenic gene expression and glucose output. In this issue of the JCI,
Foretz et al. refute this hypothesis by showing that AMPK is dispensable for
the effects of metformin on hepatic glucose output in primary hepatocytes;
rather, their data suggest that the antidiabetic effects of metformin in the
liver are mediated directly by reducing energy charge.
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Metformin in the treatment
of type 2 diabetes
The increasing worldwide incidence of obesity is driving an epidemic of type 2 diabetes
mellitus (T2DM), with global prevalence of
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the disease predicted to reach 5.4%, or 300
million people by 2025 (1). Individuals are
deemed to have T2DM if they have elevated
serum glucose levels — a pathology typically preceded by peripheral insulin resistance
and hyperinsulinemia without hyperglycemia — manifest by an impaired insulinstimulated glucose uptake and an impaired
reduction in glucose output from the liver.
T2DM and insulin resistance are associated with increased incidence of serious
cardiovascular morbidity and mortality,
and collectively these conditions contribute to the cluster of pathologies termed the
metabolic syndrome. A mainstay of pharmacological therapy for individuals with
T2DM is the biguanide drug metformin,
one of only two commonly used drugs that
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